Newsroom
Latest News
Washington, DC – Congresswoman Diana DeGette, co-chair of the Congressional Pro Choice Caucus, led more than two hundred of her congressional colleagues in sending a letter to Secretary of Health and Human Services Alex Azar expressing opposition to the implementation of a domestic gag rule on Title X, the only federal grant program solely dedicated to family planning and related preventive services.
Washington, DC – Needless delays in bringing safe over-the-counter medicines to market – and in clarifying the use of existing OTC medicines – will soon be a thing of the past thanks to committee approval today of a bipartisan bill led by Congresswoman Diana DeGette (D-CO) that reforms the way the Food and Drug Administration reviews and approves such products.
The head of a major pharmaceutical distributor apologized before Congress on Tuesday for not doing more to stop the shipment of millions of powerful prescription opioids to pharmacies in two small West Virginia towns, while another industry leader admitted that his company contributed to the nation's opioid crisis.
Cardinal Health Executive Chairman George Barrett said he is sorry that the company did not act faster to halt millions of hydrocodone and oxycodone pills to the pharmacies in West Virginia, which has the nation's highest rate of opioid overdose death.
Denver - Congresswoman Diana DeGette (D-CO), the Ranking Democrat on the Oversight and Investigations Subcommittee of the Energy and Commerce Committee, today sent a letter to Environmental Protection Agency (EPA) Administrator Scott Pruitt asking him to provide further details regarding his legally dubious real estate dealings with lobbyists while serving as a public official in Oklahoma.
Denver – On the cusp of the national launch this weekend of the innovative All of Us research program to advance medical science, Congresswoman Diana DeGette (D-CO), co-author of the law that created the program, urged every eligible American to take part.
"This is the future of biomedical research, and everybody has a chance to make a difference," DeGette said. "It's so exciting to see All of Us come together, in line with President Barack Obama's vision and the guidelines that we put into law to make this the biggest and most diverse long-term health research program ever.
U.S. Rep. Diana DeGette took time this week to sit down with Denver-area reporters and the Englewood City Council to talk about the opioid crisis, movements on DACA policy for undocumented immigrants, housing and homelessness. She represents Denver, Englewood, Sheridan, Cherry Hills Village, Bow Mar and unincorporated areas west of Littleton.
Here's what the 1st Congressional District representative had to say at her Denver office to reporters May 3, and at the Englewood Civic Center May 4.
Help from above
Denver - Oversight and Investigations Subcommittee Ranking Member Diana DeGette (D-CO) joined fellow Democratic leaders on the Energy and Commerce Committee in sending a letter to Environmental Protection Agency (EPA) Administrator Scott Pruitt today raising a series of questions following reports that a lobbyist, whose wife rented a $50-a-night condo to Pruitt, atte
Denver – Today the Environmental Protection Agency officially designated Denver and the rest of the Front Range as out of compliance with the maximum ozone standard set by U.S. law in 2015. In response, Congresswoman Diana DeGette (D-CO), a senior member of the House Energy and Commerce Committee, said making this declaration was a mere first step toward cleaner air for Colorado at a time when the EPA is working to undo air quality protections on other fronts.
DENVER – Environmental Protection Agency Administrator Scott Pruitt was grilled Thursday in two U.S. House committees over a host of ethical questions related to his spending of taxpayer money and ties to lobbyists, including tough questions from Rep. Diana DeGette.
Washington, DC – There are multiple barriers to reducing the surging cost of insulin; Congressional Diabetes Caucus co-chairs Diana DeGette (D-CO) and Tom Reed (R-NY) have found that value-based contracting is one avenue that is worth exploring. DeGette and Reed today released the latest insights from their outreach to stakeholders as part of their ongoing investigation of insulin costs.